SAN ANTONIO, August 24, 2022--Hera Biotech has closed a $1.9 million financing to support the commercialization of its non-surgical diagnostic ...
News
- Hera Biotech Closes Oversubscribed $1.9 Million Seed Raise For Novel ... - Yahoo Finance
- Hera Biotech Closes Oversubscribed $1.9 Million Seed Raise For Novel Diagnostic ... - Benzinga
Hera Biotech is developing the world's first non-surgical test for definitive diagnosis and staging of endometriosis. San Antonio-based medical ...
- LumaBridge Announces Growth Equity Investment From Summit Partners | National
SAN ANTONIO and BOSTON, Aug. ... LumaBridge serves as a strategic partner to emerging biopharma and biotech companies, offering full outsourced ...
- Study Reveals Benefits Of Robotic Surgery In Cases Of Advanced Kidney Cancer
... Mays Cancer Center and Department of Urology at UT Health San Antonio reveal that robotic ... Biotech Stocks Facing FDA Decision In March 2022.
- Legendary Hemisfair in San Antonio art gets some overdue TLC | TPR - Texas Public Radio
City of San Antonio. /. Workers detailing Juan O'Gorman's Confluence of Civilizations mural. It's one of San Antonio's ...